Radioiodine ablation is preferred in
## Core Concept
Radioiodine ablation is a treatment approach that utilizes radioactive iodine (I-131) to destroy thyroid tissue. It is primarily used in the management of thyroid cancer and hyperthyroidism. The effectiveness of radioiodine ablation depends on the ability of thyroid cells to uptake iodine.
## Why the Correct Answer is Right
The correct answer, **D. Post-operative ablation of thyroid remnant in differentiated thyroid cancer**, is the preferred use of radioiodine ablation because it helps in eliminating any residual thyroid tissue and microscopic disease that might remain after surgery. This approach is particularly beneficial in patients with differentiated thyroid cancers (such as papillary and follicular thyroid cancer) as it facilitates the use of thyroglobulin as a tumor marker for recurrence and allows for the administration of radioactive iodine for any potential residual or metastatic disease.
## Why Each Wrong Option is Incorrect
- **Option A: Graves' disease with large goiter** - While radioiodine ablation can be used to treat Graves' disease, its use is generally reserved for patients with a small to moderate-sized goiter and those who are euthyroid or mildly hyperthyroid on antithyroid medications. Large goiters may require surgical intervention.
- **Option B: Toxic multinodular goiter** - Radioiodine can be used for toxic multinodular goiter but is often considered for patients who are poor surgical candidates or have a low risk of thyroid cancer. It might not be as effective as surgery for very large goiters.
- **Option C: Hyperthyroidism due to thyroiditis** - Radioiodine ablation is not typically used for hyperthyroidism caused by thyroiditis, as this condition is usually self-limiting and managed supportively.
## Clinical Pearl / High-Yield Fact
A key point to remember is that radioiodine ablation is particularly useful in the management of **differentiated thyroid cancer** (papillary and follicular) for ablation of thyroid remnants, which helps in follow-up and management of potential recurrence.
## Correct Answer: D. Post-operative ablation of thyroid remnant in differentiated thyroid cancer.